Mathers Edward T. - 10 Jul 2024 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
10 Jul 2024
Net transactions value
$0
Form type
4
Filing time
12 Jul 2024, 16:30:25 UTC
Previous filing
25 Jun 2024
Next filing
12 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +62,500 $0.000000 62,500 10 Jul 2024 Common Stock 62,500 $0.3100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2025 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date.